Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A form of myositis that is characterized by the formation of connective tissue within the muscle.
No clinical trials have been registered for myositis fibrosa.
1 publication has been identified in PubMed for myositis fibrosa. Research spans Basic Science / Preclinical (100%).
Damasceno TR (2024). [PMID: 39258653](https://pubmed.ncbi.nlm.nih.gov/39258653/). *Arq Bras Cardiol*. [Basic Science / Preclinical]
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 1:00 AM UTC
AI-curated news mentioning myositis fibrosa
Updated Jun 6, 2026
A case report details a rare overlap syndrome of pembrolizumab-induced myocarditis, myositis, and myasthenia gravis in a patient with endometrial carcinoma. The report highlights concurrent hepatitis and thyroiditis, emphasizing the complexity of immune-related adverse events.
A recent study highlights the complexities of diagnosing and treating calcinosis cutis and delayed-onset myositis in a patient with suspected localized scleroderma. This case underscores the need for careful evaluation in rare disease presentations.